| Product Code: ETC11877103 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Enteric Disease Testing and Therapeutic Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Israel Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.6 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of enteric diseases in Israel |
4.2.2 Growing awareness about the importance of early detection and treatment |
4.2.3 Technological advancements in enteric disease testing and therapeutics |
4.3 Market Restraints |
4.3.1 High cost associated with enteric disease testing and treatment |
4.3.2 Limited access to healthcare facilities in certain regions of Israel |
4.3.3 Stringent regulatory requirements for approval of enteric disease testing and therapeutic products |
5 Israel Enteric Disease Testing and Therapeutic Market Trends |
6 Israel Enteric Disease Testing and Therapeutic Market, By Types |
6.1 Israel Enteric Disease Testing and Therapeutic Market, By Testing Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Testing Type, 2021 - 2031F |
6.1.3 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.4 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Stool Culture, 2021 - 2031F |
6.1.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Serological Testing, 2021 - 2031F |
6.1.6 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Rapid Testing Kits, 2021 - 2031F |
6.2 Israel Enteric Disease Testing and Therapeutic Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Gastroenteritis, 2021 - 2031F |
6.2.3 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Cholera, 2021 - 2031F |
6.2.4 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Salmonella Infection, 2021 - 2031F |
6.2.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By E. Coli Infection, 2021 - 2031F |
6.3 Israel Enteric Disease Testing and Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.4 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Israel Enteric Disease Testing and Therapeutic Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.4.3 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.4.4 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Probiotic Therapy, 2021 - 2031F |
6.4.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Vaccine Therapy, 2021 - 2031F |
6.5 Israel Enteric Disease Testing and Therapeutic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.4 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.5 Israel Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Israel Enteric Disease Testing and Therapeutic Market Import-Export Trade Statistics |
7.1 Israel Enteric Disease Testing and Therapeutic Market Export to Major Countries |
7.2 Israel Enteric Disease Testing and Therapeutic Market Imports from Major Countries |
8 Israel Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
8.1 Percentage increase in the number of enteric disease tests conducted annually in Israel |
8.2 Adoption rate of new enteric disease testing technologies in healthcare facilities |
8.3 Patient satisfaction levels with enteric disease testing and therapeutic services |
9 Israel Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
9.1 Israel Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.2 Israel Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Israel Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Israel Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
10.1 Israel Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Israel Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here